Observational study to examine the usefulness of denosumab in postmenopausal breast cancer patients
Phase 4
- Conditions
- postmenopausal breast cancer patients
- Registration Number
- JPRN-UMIN000017328
- Lead Sponsor
- Physician -managed clinical trial
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with a history of hypersensitivity to aromatase inhibitors and denosumab 2.Patients with bone metastases 3.More than one year have passed after radical surgery. 4.More than six months have passed after start of denosumab 5.Patients undergoing treatment with bisphosphonates
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in bone mineral density , The change of bone metabolism markers , Safety
- Secondary Outcome Measures
Name Time Method Bone metastasis-free survival , Recurrence-free survival , Survival